Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events patient preferences considered first time fda decision approve first kind obesity
Webinar: Introduction to Network Meta-analysis Share on: Thursday, January 17, 2019, 10 - 11am Watch the recording Healthcare Treatment Decisions Clinicians, patients, and health-policy makers often need to decide which treatment is “best” based on all …
… and proactive efforts toward workplace diversity. The first three categories were weighted more heavily for this … package includes a competitive base salary, generous paid time off, merit based annual increases, bonus opportunities …
… in the AMCP Format provide information that healthcare decision-makers can use to determine which products provide …
… research and consulting services in health economics, patient-centered outcomes research, market access, and … As the only non-profit, independent organization of its kind, our multidisciplinary team of over 350 professionals-- …
… illnesses. Recent projects have included: Database studies Decision-analytic models (cost-effectiveness, budget impact) … development Literature reviews Meta-analysis studies Patient-reported outcomes (PRO) studies (including instrument …
… the aorta actively contracts in rhythm with the heart was first presented in a set of papers published in the 1950s and …
… market access experts , 60+ health economic experts , 30+ patient-centered outcomes assessment experts and …
… in the AMCP Format provide information that healthcare decision-makers need to decide which products will be most … important timeline information and information relevant to patient access. Include RWE that contributes significantly to … product’s key clinical and economic evidence to healthcare decision-makers. For more than 20 years, the Value & Access …
… launched in 2007 by the US Food and Drug Administration (FDA), is a national electronic data system created to help monitor the safety of FDA-regulated products, including drugs, vaccines, biologics, … with CBER and other partners in the BEST System to address FDA regulatory priorities around new COVID-19 vaccines. …
… Website Impacting Innovation, Value, and Healthcare Decision Making Our team of experts are looking forward to …